APA (7th ed.) Citation

Kriegsmann, K., Schöning, T., Schwarzbich, M., Cremer, M., Dittrich, T., Ho, A. D., & Witzens-Harig, M. (2016). Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma. BioMed Central; Springer.

Chicago Style (17th ed.) Citation

Kriegsmann, Katharina, Tilman Schöning, Mark-Alexander Schwarzbich, Martin Cremer, Tobias Dittrich, Anthony Dick Ho, and Mathias Witzens-Harig. Minimal Renal Toxicity After Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma. London; Berlin; Heidelberg: BioMed Central; Springer, 2016.

MLA (9th ed.) Citation

Kriegsmann, Katharina, et al. Minimal Renal Toxicity After Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma. BioMed Central; Springer, 2016.